Atara Biotherapeutics, INC. (ATRA) SEC Filings — 2024
33 SEC filings for Atara Biotherapeutics, INC. (ATRA) in 2024.
Filings
- Atara Biotherapeutics Changes Fiscal Year End — 8-K · Dec 23, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Atara Biotherapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Atara Biotherapeutics Announces Executive and Board Changes — 8-K · Oct 15, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Sep 13, 2024
- Adiumentum Capital Fund Amends Atara Biotherapeutics Stake — SC 13D/A · Sep 5, 2024
- Atara Biotherapeutics Announces Board and Executive Changes — 8-K · Sep 3, 2024
- Atara Biotherapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Atara Biotherapeutics Files 8-K Report — 8-K · Jul 17, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Jul 8, 2024
- Atara Biotherapeutics Files 8-K: Rights, Bylaws, and Financials Updated — 8-K · Jun 20, 2024
- Atara Biotherapeutics Files 8-K — 8-K · Jun 17, 2024
- Atara Biotherapeutics Files 8-K for Security Holder Vote — 8-K · Jun 11, 2024
- Adiumentum Capital Fund I LP Files 13D on Atara Biotherapeutics — SC 13D · May 22, 2024
- Atara Biotherapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Atara Biotherapeutics Files DEF 14A for Annual Meeting — DEF 14A · Apr 26, 2024
- Atara Biotherapeutics Names New CEO, Board Changes — 8-K · Mar 29, 2024
- Atara Biotherapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Atara Biotherapeutics, INC. SC 13G Filing — SC 13G · Mar 18, 2024
- Atara Biotherapeutics Reports Executive Changes and Compensation Updates — 8-K · Feb 23, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Atara Biotherapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Wasatch Advisors LP Divests Entire Stake in Atara Biotherapeutics — SC 13G/A · Feb 9, 2024
- Goldman Sachs Amends Atara Bio Stake on Dec 29 — SC 13G/A · Feb 6, 2024
- BlackRock Amends Atara Bio Stake, Signals Portfolio Adjustment — SC 13G/A · Jan 26, 2024
- State Street Corp. Updates Passive Stake in Atara Biotherapeutics — SC 13G/A · Jan 22, 2024
- Atara Biotherapeutics Reports Material Agreement, Nasdaq Listing Issues — 8-K · Jan 9, 2024
- Baupost Group Slashes Atara Bio Stake to 10.7% from 19.9% — SC 13G/A · Jan 9, 2024
- Atara Biotherapeutics 8-K: Exit Costs, Officer Comp Changes — 8-K · Jan 8, 2024